Compare CNS & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNS | NVST |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.6B |
| IPO Year | 2004 | 2019 |
| Metric | CNS | NVST |
|---|---|---|
| Price | $68.03 | $23.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $72.50 | $21.38 |
| AVG Volume (30 Days) | 262.7K | ★ 2.1M |
| Earning Date | 01-22-2026 | 02-05-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | ★ 18.87 | N/A |
| EPS | ★ 3.19 | 0.09 |
| Revenue | $552,096,000.00 | ★ $2,621,800,000.00 |
| Revenue This Year | $8.24 | $7.42 |
| Revenue Next Year | $9.40 | $3.60 |
| P/E Ratio | ★ $21.35 | $274.73 |
| Revenue Growth | ★ 11.13 | 4.73 |
| 52 Week Low | $58.39 | $14.22 |
| 52 Week High | $91.07 | $23.97 |
| Indicator | CNS | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 68.93 | 69.59 |
| Support Level | $62.43 | $21.58 |
| Resistance Level | $64.82 | $22.14 |
| Average True Range (ATR) | 1.48 | 0.56 |
| MACD | 0.59 | 0.11 |
| Stochastic Oscillator | 84.42 | 82.67 |
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two thirds of its $90.9 billion in managed assets at the end of September 2025. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (26%) of its managed assets (base management fees) from institutional clients, 48% (54%) from open-end funds, and 13% (20%) from closed-end funds.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.